Study directory

Anxiety studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4175studies shown
Showing 685-696 of 4,175
Behavioral study icon
Active Not RecruitingNCT05249543

Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy

This summary needs review. Please check the official study record and contact the research team for details.

In Stockholm
Why is this study shown?

This study is directly about Anxiety.

Anxiety, PTSD, ...BehavioralFrom 18 Years to 65 Years
Countries
Sweden
Sponsor
Karolinska Institutet
Condition
Anxiety, PTSD, ...
Device study icon
Active Not RecruitingNCT04931134

Treatment of Anxiety Disorders With Trigeminal Nerve Stimulation

This summary needs review. Please check the official study record and contact the research team for details.

In Kingston
Why is this study shown?

This study is directly about Anxiety.

AnxietyDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
Canada
Sponsor
Dr. Rafael Freire
Condition
Anxiety
Drug study icon
Not recruitingISRCTN18346744

Safety study of NTX-1955 in anxiety

This study is not recruiting in the United Kingdom. It is testing NTX-1955 for anxiety.

In United Kingdom
Why is this study shown?

This study is directly about Anxiety.

AnxietyOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
Newleos Therapeutics
Condition
Anxiety
Drug study icon
Not recruitingISRCTN03554974

Agomelatine for anxiety

This study is not recruiting in Argentina, in Czechia, in Finland, .... It is testing agomelatine for anxiety.

In Argentina
Why is this study shown?

This study is directly about Anxiety.

AnxietyOtherOver 18 Years
Countries
Argentina, Czechia, Finland, ...
Sponsor
Institut de Recherches Internationales Servier (France)
Condition
Anxiety
Drug study icon
Not recruitingISRCTN13032035

Phase III study to prove the efficacy, safety and tolerability of Silexan® in people with anxiety disorder

This study is looking at whether Silexan® 80 mg (1 capsule) per day or placebo orally for 10 weeks can help people with anxiety not otherwise specified, Mental and Behavioural Disorders, or Other anxiety. Participants receive a study treatment and complete follow-up visits and assessments.

In Germany
Why is this study shown?

This study is directly about Anxiety.

AnxietyOtherOver 18 Years
Countries
Germany
Sponsor
Dr. Willmar Schwabe GmbH & Co. KG (Germany)
Condition
Anxiety
Drug study icon
Recruitment unclearEUCTR 2014-004475-23

Enhancement of exposure therapy for social anxiety disorder with testosterone: A randomized clinical trial

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Netherlands
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrugA study involving a medication or substance.
Countries
Netherlands
Sponsor
Radboud University Nijmegen
Condition
Anxiety
Behavioral study icon
Not recruitingISRCTN56220277

Mindfulness based task concentration training versus cognitive therapy for social anxiety disorder

This study is looking at whether a digital support tool can help people with Social anxiety or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.

In Netherlands
Why is this study shown?

This study is directly about Anxiety.

AnxietyOther
Countries
Netherlands
Sponsor
Maastricht University (Netherlands)
Condition
Anxiety
Drug study icon
Not recruitingISRCTN45667531

The effect of group cognitive behavior combined hypnotherapy on neuroendocrine and physical symptoms in people with anxiety disorders

This study is testing a medication approach for people with anxiety or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In China
Why is this study shown?

This study is directly about Anxiety.

AnxietyOther
Countries
China
Sponsor
Universiti Sains Malaysia
Condition
Anxiety
Drug study icon
Active Not RecruitingNCT06741228

Study of DT120 for Generalized Anxiety Disorder (Voyage)

This study is active but not recruiting in the United States. It focuses on anxiety.

Multiple locations, including Gilbert
Why is this study shown?

This study is directly about Anxiety.

AnxietyDrugFrom 18 Years to 74 Years
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Anxiety
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.